Sabtu, 08 September 2018

CURAIZON

We solve real-world problems enormously by helping patients take their medications properly
medical researchers are challenged to find new, improved drugs and courses of treatment for chronic disease. But, what if the answer to improving health outcomes for many patients was simpler than developing new drugs? What if it was as simple as ensuring more patients stick to their treatment regimens?
Medical non-adherence is a massive challenge all over the world. According to the World Health Organization, half of patients in long-term treatment for chronic illnesses such as HIV, cancer and hypertension do not adhere to treatment plans – and rates are even lower in developing countries. While low adherence means individual patients have more difficulty managing disease, it also creates huge costs for healthcare and insurance companies.
Until now, many clinicians have relied on low-tech solutions for improving medical adherence – for example, providing patients with labeled pill boxes or sending digital reminders via email or text message. While these tactics are somewhat effective in improving adherence, there’s a smarter solution: the Internet of Things.
The value of CuraToken ™ is based on real solutions to real problems.
Play videos and learn more about Curaizon ™

What does the company do?
We aim to improve drug adherence and bring benefits that change the game for patients and healthcare providers by becoming the leading supplier of compliance and data solutions worldwide.

What's unique about the company?
Our solutions work with patients, their families, and health care providers to ensure that patients take their medication as prescribed through a series of outreach tools, supported by predictive modeling tools and behavioral analysis, to improve drug adherence levels.

What problem does the company solve?
Our CuraServe technology helps ensure that patients take their medication as prescribed by their doctor. By doing this, we help patients live longer and healthier lives. We also reduce the cost of health care that occurs when patients fail to take their medication properly.

How do you create value to support your CuraTokens?
Our CuraServe ™ technology generates a large amount of unique and real-time data that shows how people use their most valuable medicines for various groups including pharmaceutical companies, medical researchers, and biotech companies. CuraTokens ™ allows the token owner to access data to create queries. When our solution was launched to more patients in more countries. The more data we generate, the more valuable that CuraTokens ™ becomes.

Who is your target customer?
Curaizon ™ sells its compliance solutions (CuraServe ™) to national health services worldwide. Our end users are health care patients who take any form of medication. We also work with industry academia, pharmacy and biotechnology, as well as other data users through our CuraData ™ solution.

What is your geographic target market?
Curaizon targets countries with national health services. It currently includes 1.4 billion people and that number continues to grow.

What is the market potential?
The global cost of noncompliance is over € 600 billion annually and generates hundreds of thousands of lives lost prematurely. Adherence to chronic and long-term diseases is less than 50%.

Curaizon ™ ecosystem

CuraToken ™ Utility Tokens (CTKN) allows token holders to access our exclusive and anonymous medical data on blockchain.
  • CuraTokens ™ is the only way to access Curaizon ™ technology.
  • CuraToken ™ holders can access data that uses strong analytics, predictions, AIs and large data in the fight against drug non-compliance.
  • CuraTokens ™ provides real-time analysis of patient behavior and compliance.
  • CuraTokens ™ allows the use of blockchain technology to manage authentication, confidentiality and accountability by allowing individuals to control their data, providing protection, security, and compliance with all required regulations, including GDPR.
  • CuraTokens ™ facilitates partnerships with medical and pharmaceutical organizations through a token reward system.
  • The holders of CuraToken ™ know that they save lives around the world by helping solve the problem of drug non-compliance.
January 2016
Development of CuraServe ™ Starts

June 2017
The CuraServe ™ Testing takes place

February 2018
Rilis Full Alpha CuraData ™

June 1, 2018
Start Token Presale

June 8, 2018
Token Public Sale Begins

November 2018
Full CuraData ™ Beta Release

March 2019
CuraServe ™ Public Release

July 2019
CuraData ™ Platform Growth

2020
Release Curadata ™ 2.0

Our team combines passion, innovation, and expertise with experience in health, finance, operations, marketing, and technology LEADERSHIP

For more information :
USER NAME BTT: DEWI08


Tidak ada komentar:

Posting Komentar

DEC777 Decentralized Exchange.

What is DEC777 Decentralized Exchange If you’re nеw tо contract-for-difference trading, оnе оf thе biggest decisions уоu саn mаkе іѕ choosi...